NCT02228811View on ClinicalTrials.gov

A Study of DCC-2701 in Participants With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2017

Study Completion Date

January 31, 2018

Conditions
Locally Advanced TumorsMetastatic Solid TumorsCancers With MET Genomic AlterationsCancers With TRK Genomic Alterations
Interventions
DRUG

DCC-2701 tablet

Trial Locations (5)

19104

The Hospital of the University of Pennsylvania, Philadelphia

37232

Vanderbilt University Medical Center, Nashville

77030

MD Anderson Cancer Center, Houston

80045

University of Colorado Hospital, Aurora

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

Deciphera Pharmaceuticals, LLC

INDUSTRY